Effect of the IADPSG screening strategy for gestational diabetes on perinatal outcomes in Switzerland
Version
Published
Date Issued
2021-04-22
Author(s)
Type
Article
Language
English
Abstract
Aims: To evaluate the impact adoption of the International Association of Diabetes and
Pregnancy Study Groups (IADPSG) criteria on prevalence of gestational diabetes mellitus
(GDM) and risks of perinatal outcomes.
Methods: Retrospectively, 155,103 women screened with selective two step criteria in
Switzerland in period 1 (2005–2010) were compared to 170,427 women screened with
IADPSG criteria in period 2 (2012–2017). GDM prevalence over time was established and
multivariable regression used to assess variation in risks for GDM related events and perinatal outcomes.
Results: GDM prevalence increased steadily over both study periods from 1.8% to 9.0%. A
risk reduction of GDM-related events was shown only for women with one or two risk factors for GDM present (relative risk (95% confidence interval)): (0.93 (0.90,0.97), 0.90
(0.83,0.96)). The comparison of perinatal outcomes between the two study periods revealed a significant lower risk for newborns large for gestational age (LGA) (0.93 (0.91–0.95)), preterm delivery (0.94 (0.92–0.97)) and neonatal hypoglycemia (0.83 (0.77–0.90)) in period 2.
Conclusion: The introduction of the IADPSG criteria for the screening of GDM increased
prevalence by threefold with no substantial improvements in GDM related events for
women without risk factors but reduced the risks for LGA, neonatal hypoglycemia and preterm birth.
Pregnancy Study Groups (IADPSG) criteria on prevalence of gestational diabetes mellitus
(GDM) and risks of perinatal outcomes.
Methods: Retrospectively, 155,103 women screened with selective two step criteria in
Switzerland in period 1 (2005–2010) were compared to 170,427 women screened with
IADPSG criteria in period 2 (2012–2017). GDM prevalence over time was established and
multivariable regression used to assess variation in risks for GDM related events and perinatal outcomes.
Results: GDM prevalence increased steadily over both study periods from 1.8% to 9.0%. A
risk reduction of GDM-related events was shown only for women with one or two risk factors for GDM present (relative risk (95% confidence interval)): (0.93 (0.90,0.97), 0.90
(0.83,0.96)). The comparison of perinatal outcomes between the two study periods revealed a significant lower risk for newborns large for gestational age (LGA) (0.93 (0.91–0.95)), preterm delivery (0.94 (0.92–0.97)) and neonatal hypoglycemia (0.83 (0.77–0.90)) in period 2.
Conclusion: The introduction of the IADPSG criteria for the screening of GDM increased
prevalence by threefold with no substantial improvements in GDM related events for
women without risk factors but reduced the risks for LGA, neonatal hypoglycemia and preterm birth.
Subjects
RG Gynecology and obstetrics
Publisher DOI
Journal
Diabetes Research and Clinical Practice
ISSN
1872-8227
Organization
Volume
175
Publisher
Elsevier
Submitter
Grand-Guillaume-Perrenoud, Jean Anthony
Citation apa
Aubry, E., Raio, L., & Oelhafen, S. (2021). Effect of the IADPSG screening strategy for gestational diabetes on perinatal outcomes in Switzerland. In Diabetes Research and Clinical Practice (Vol. 175). Elsevier. https://doi.org/10.24451/arbor.15231
File(s)![Thumbnail Image]()
Loading...
open access
Name
Aubry et al_2021.pdf
License
Attribution-NonCommercial-NoDerivatives 4.0 International
Version
published
Size
565.99 KB
Format
Adobe PDF
Checksum (MD5)
e2204545683f768e24cc900ce5f75fe2
